HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of sleep disorders after traumatic brain injury.

AbstractSTUDY OBJECTIVES:
Determine whether treatment of sleep disorders identified in brain injured adults would result in resolution of those sleep disorders and improvement of symptoms and daytime function.
METHODS:
Prospective evaluation of unselected traumatic brain injury patients with nocturnal polysomnography (NPSG), multiple sleep latency test (MSLT), Epworth Sleepiness Scale (ESS), and neuropsychological testing including Psychomotor Vigilance Test (PVT), Profile of Mood States (POMS), and Functional Outcome of Sleep Questionnaire (FOSQ) before and after treatment with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA), modafinil (200 mg) for narcolepsy and posttraumatic hypersomnia (PTH), or pramipexole (0.375 mg) for periodic limb movements in sleep (PLMS).
SETTING:
Three academic medical centers.
PARTICIPANTS:
Fifty-seven (57) adults > or = 3 months post traumatic brain injury (TBI).
MEASUREMENTS AND RESULTS:
Abnormal sleep studies were found in 22 subjects (39%), of whom 13 (23%) had OSA, 2 (3%) had PTH, 3 (5%) had narcolepsy, 4 (7%) had PLMS, and 12 had objective excessive daytime sleepiness with MSLT score < 10 minutes. Apneas, hypopneas, and snoring were eliminated by CPAP in OSA subjects, but there was no significant change in MSLT scores. Periodic limb movements were eliminated with pramipexole. One of 3 narcolepsy subjects and 1 of 2 PTH subjects had resolution of hypersomnia with modafinil. There was no significant change in FOSQ, POMS, or PVT results after treatment.
CONCLUSIONS:
Treatment of sleep disorders after TBI may result in polysomnographic resolution without change in sleepiness or neuropsychological function.
AuthorsRichard J Castriotta, Strahil Atanasov, Mark C Wilde, Brent E Masel, Jenny M Lai, Samuel T Kuna
JournalJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine (J Clin Sleep Med) Vol. 5 Issue 2 Pg. 137-44 (Apr 15 2009) ISSN: 1550-9389 [Print] United States
PMID19968047 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzhydryl Compounds
  • Benzothiazoles
  • Central Nervous System Stimulants
  • Dopamine Agonists
  • Pramipexole
  • Modafinil
Topics
  • Adult
  • Benzhydryl Compounds (therapeutic use)
  • Benzothiazoles (therapeutic use)
  • Brain Injuries (complications, rehabilitation)
  • Central Nervous System Stimulants (therapeutic use)
  • Disorders of Excessive Somnolence (drug therapy, etiology)
  • Dopamine Agonists (therapeutic use)
  • Female
  • Humans
  • Male
  • Modafinil
  • Narcolepsy (drug therapy, etiology)
  • Nocturnal Myoclonus Syndrome (drug therapy, etiology)
  • Pramipexole
  • Prospective Studies
  • Quality of Life
  • Sleep Apnea, Obstructive (etiology, therapy)
  • Sleep Wake Disorders (etiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: